周四盘中,碧迪医疗(BDX)股价大跌5.43%,引发市场广泛关注。导致股价下跌的主要原因包括:
首先,公司最新公布的2024财年第四季度业绩疲软。财报显示,碧迪医疗当季每股实际收益仅为1.04美元,远低于分析师预期的2.98美元。虽然收入和调整后每股收益均超出预期,但实际每股收益低迷引发投资者的失望情绪,对公司未来前景产生担忧。
其次,碧迪医疗正在推进将生物科学和诊断解决方案业务与其它业务分拆的计划。分拆后新公司将专注于医疗技术领域,并加大在研发和资本投放等领域的投入。这一调整可能令投资者对公司整体战略的变动产生不确定性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.